Home » Topics » BioWorld Science

BioWorld Science
RSS

Bavarian Nordic begins first-in-human study of MVA-BN-WEV for equine encephalitis virus

Oct. 8, 2019

Three win Nobel for hypoxia work

Oct. 8, 2019

Evaluating gepotidacin in the treatment of uncomplicated urinary tract infections: a phase IIa study

Oct. 8, 2019

FDA approves Beovu for wet age-related macular degeneration

Oct. 8, 2019

Advaxis updates median overall survival data from phase I/II study of ADXS-PSA in metastatic CRPC

Oct. 8, 2019

BARDA contract supports Platelet BioGenesis' development of donor-independent platelets

Oct. 8, 2019

Phase III extension study of VM-202 in diabetic peripheral neuropathy meets primary endpoint

Oct. 8, 2019

Dermavant initiates phase IIa study of cerdulatinib gel in vitiligo

Oct. 8, 2019

Genentech patents TRPA1 antagonists

Oct. 8, 2019

Aerie Pharmaceuticals synthesizes new kinase inhibitors

Oct. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...